Skip to content
  • Home
  • Contact Us
  • About Us
  • Sitemap
  • Home
  • Contact Us
  • About Us
  • Sitemap
  • General
  • Business
  • Education
  • Government
  • Medical
  • Entertainment
  • Sports
  • French
  • Press Releases
    • PR-French
  • General
  • Business
  • Education
  • Government
  • Medical
  • Entertainment
  • Sports
  • French
  • Press Releases
    • PR-French
Search
Day: October 21, 2024

Leil Storage: Green File Storage for Africa

October 21, 2024

Leil Storage for Africa Leil Storage announces the expansion of its Green Storage Initiative, an endeavor set to revolutionize file storage across Africa. This initiative,

Read More

Leil Storage: Green File Storage for Africa

October 21, 2024

Leil Storage for Africa Leil Storage announces the expansion of its Green Storage Initiative, an endeavor set to revolutionize file storage across Africa. This initiative,

Read More

Transforming Finance Through Scalable Infrastructure: Join the Digital Finance Breakfast in Sandton

October 21, 2024

JOHANNESBURG, Oct. 21, 2024 (GLOBE NEWSWIRE) — IT News Africa, in partnership with OADC, is excited to announce an exclusive Digital Finance Breakfast on 29 October 2024 at the Radisson Blu, Sandton. This

Read More

Transforming Finance Through Scalable Infrastructure: Join the Digital Finance Breakfast in Sandton

October 21, 2024

JOHANNESBURG, Oct. 21, 2024 (GLOBE NEWSWIRE) — IT News Africa, in partnership with OADC, is excited to announce an exclusive Digital Finance Breakfast on 29 October 2024 at the Radisson Blu, Sandton. This

Read More

Angelini Pharma Enters Into An Exclusive Option Agreement With Cureverse to License Global Development and Commercialization Rights For A Novel and Innovative Clinical-Stage Brain Health Asset

October 21, 2024

The agreement gives Angelini Pharma an option to exclusive licensing rights to develop and commercialize CV-011, a clinical Phase 1 investigational novel compound with broad

Read More

Angelini Pharma Enters Into An Exclusive Option Agreement With Cureverse to License Global Development and Commercialization Rights For A Novel and Innovative Clinical-Stage Brain Health Asset

October 21, 2024

The agreement gives Angelini Pharma an option to exclusive licensing rights to develop and commercialize CV-011, a clinical Phase 1 investigational novel compound with broad

Read More
Page1 Page2 Page3 … Page12
RECENT POSTS

WHO Warns Of A Record-breaking Ebola Outbreak In Congo

August 13, 2026

Conflict-Displaced Women in Eastern DRC Face Increasing Sexual Violence Risk

August 13, 2026

Ebola Outbreak in Eastern DR Congo Claims Over 300 Children; New Vaccine Trials Recommended

August 7, 2026

DR Congo Ebola Outbreak Surpasses 4,000 Cases Amidst Expanding Health Response

August 7, 2026

Ebola Cases Surpass 4,000 in Democratic Republic of Congo

August 7, 2026

Antwerp Confronts Colonial Past with Monument to Human Zoo Victims

August 7, 2026

Ebola Death Toll Tops 1,800 in DRC

August 7, 2026

DRCs Largest Ebola Outbreak on Record: Active Conflict and Armed Groups Hamper the Response

August 7, 2026
Copyright © 2026 Le Congo Tribune. All Rights Reserved.